Jove
Visualize
Contact Us

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling <i>in vitro</i>.

medRxiv : the preprint server for health sciences·2025
Same author

Five-Year Follow-Up Study of Single Dose Challenges in the Diagnosis and Management of Cow's Milk Allergy in Infants.

Allergy·2025
Same author

Trajectories of allergic diseases in children: Destination unknown?

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

A pen-demic? Audit of existing adrenaline auto-injector prescription among new referrals to pediatric allergy clinics, according to the EAACI guidelines.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Gene-Environment Interaction Affects Risk of Atopic Eczema: Population and In Vitro Studies.

Allergy·2025
Same author

Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464].

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Recent advances in peanut allergy.

Jonathan O'B Hourihane1

  • 1Division of Infection Inflammation and Repair, Southampton University Hospitals NHS Trust, Southampton, UK. j.hourihane@soton.ac.uk

Current Opinion in Allergy and Clinical Immunology
|June 5, 2002
PubMed
Summary

Peanut allergy causes severe reactions, but improved communication and personalized plans can help. Some children may outgrow this common food allergy, while new treatments show promise.

Area of Science:

  • Allergy and Immunology
  • Food Science

Background:

  • Peanut allergy is a leading cause of severe, life-threatening allergic reactions.
  • Strict avoidance is challenging, leading to frequent reactions outside the home.
  • Factors influencing peanut allergenicity and potential treatment advancements are critical areas of research.

Purpose of the Study:

  • To review current understanding of peanut allergy management and potential future directions.
  • To highlight the impact of communication, personalized care, and cooking methods on peanut allergy.
  • To discuss emerging therapeutic strategies for peanut allergy.

Main Methods:

  • Literature review and synthesis of existing research on peanut allergy.
  • Analysis of factors contributing to reaction severity and prevalence.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

  • Exploration of novel treatment modalities, including immunotherapy and vaccines.

    • Main Results:

    • Roasted peanuts appear more allergenic than boiled or fried varieties.
    • Approximately 25% of young individuals with peanut allergy may outgrow it.
    • Enhanced information sharing and personalized care plans can improve management.
    • Immunotherapy and DNA-based vaccines are progressing towards clinical trials.

    Conclusions:

    • Effective management of peanut allergy requires improved communication and tailored care plans.
    • Understanding cooking methods' impact on allergenicity is important for avoidance strategies.
    • Advancements in immunotherapy and vaccine development offer future hope for treating peanut allergy.